---
title: Aldevron vs ProBioGen AG
slug_a: aldevron
slug_b: probiogen
site: cdmo
review_signal_gate: closed
canonical_path: /compare/aldevron/probiogen
---

# Aldevron vs ProBioGen AG

Side-by-side profile data from each company listing on this directory.

## Aldevron

- Profile: [/companies/aldevron](/companies/aldevron)

Aldevron — Aldevron is a CDMO specializing in mRNA manufacturing with LNP encapsulation and fill/finish, viral vector production, plasmid DNA, and gene therapy solutions from discovery through commercialization.

Services: 15. Modalities: 5. Indications: 4. Locations: 5. Certifications: 3. The strongest documented coverage currently appears in services (15).

### Services

- Recombinant Protein Manufacturing
- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Expression: Mammalian
- Expression: Microbial
- Expression: Cell-Free

## ProBioGen AG

- Profile: [/companies/probiogen](/companies/probiogen)

ProBioGen AG — ProBioGen AG is a CDMO offering cell line development, process development, GMP manufacturing and analytical services for proteins, antibodies, viral vectors and vaccines. It also provides technology platforms for biopharmaceutical manufacturing.

Services: 19. Modalities: 5. Indications: 1. Locations: 4. Certifications: 2. The strongest documented coverage currently appears in services (19).

### Services

- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Analytical Method Development & Validation
- ICH Stability Studies
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Vaccine Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Viral Vector